Literature DB >> 17068632

[The pharmacological study of Ganoderma spores and their active components].

Zhi-bin Lin1, Peng-yun Wang.   

Abstract

Recently, the pharmacological study of Ganoderma spores and active components has become a focus of attention in the world. The present review is based on the auctorial research on Ganoderma spores. It involves pharmacological effects of Ganoderma spores and its active components, including immunomodulating effect, antitumor activity and its mechanism in vivo and in vitro, liver-protective effect, gastric ulcer preventing effect, serum glucose and blood fat depressing effects, anti-hypoxia and scavenging free redical, etc. The possible problems and their solutions in this research area are also discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17068632

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  3 in total

1.  Triterpenoids from the spores of Ganoderma lucidum.

Authors:  Bingji Ma; Wei Ren; Yan Zhou; Jinchuan Ma; Yuan Ruan; Chun-Nan Wen
Journal:  N Am J Med Sci       Date:  2011-11

2.  Effect and Mechanism of Ganoderma lucidum Spores on Alleviation of Diabetic Cardiomyopathy in a Pilot in vivo Study.

Authors:  Fahmi Shaher; Shuqiu Wang; Hongbin Qiu; Yu Hu; Yu Zhang; Weiqun Wang; Hisham Al-Ward; Mahfoudh A M Abdulghani; Salem Baldi; Shaobo Zhou
Journal:  Diabetes Metab Syndr Obes       Date:  2020-12-07       Impact factor: 3.168

3.  Intervention effects of ganoderma lucidum spores on epileptiform discharge hippocampal neurons and expression of neurotrophin-4 and N-cadherin.

Authors:  Shu-Qiu Wang; Xiao-Jie Li; Shaobo Zhou; Di-Xiang Sun; Hui Wang; Peng-Fei Cheng; Xiao-Ru Ma; Lei Liu; Jun-Xing Liu; Fang-Fang Wang; Yan-Feng Liang; Jia-Mei Wu
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.